PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?
Publication
, Conference
Rajan, SS; Lyman, GH
Published in: Value in Health
November 2011
Duke Scholars
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
November 2011
Volume
14
Issue
7
Start / End Page
A444 / A444
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Rajan, S. S., & Lyman, G. H. (2011). PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad? In Value in Health (Vol. 14, pp. A444–A444). Elsevier BV. https://doi.org/10.1016/j.jval.2011.08.1160
Rajan, S. S., and G. H. Lyman. “PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?” In Value in Health, 14:A444–A444. Elsevier BV, 2011. https://doi.org/10.1016/j.jval.2011.08.1160.
Rajan SS, Lyman GH. PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad? In: Value in Health. Elsevier BV; 2011. p. A444–A444.
Rajan, S. S., and G. H. Lyman. “PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?” Value in Health, vol. 14, no. 7, Elsevier BV, 2011, pp. A444–A444. Crossref, doi:10.1016/j.jval.2011.08.1160.
Rajan SS, Lyman GH. PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad? Value in Health. Elsevier BV; 2011. p. A444–A444.
Published In
Value in Health
DOI
ISSN
1098-3015
Publication Date
November 2011
Volume
14
Issue
7
Start / End Page
A444 / A444
Publisher
Elsevier BV
Related Subject Headings
- Health Policy & Services
- 4407 Policy and administration
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services